Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LibiGel Extension Study in HSDD
NCT01235754Phase 3Completed
- Sponsor
- BioSante Pharmaceuticals
- Start
- Oct 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Testosterone TEPI patch in hypoactive sexual desire disorder (HSDD), sponsored by BioSante Pharmaceuticals. Started Oct 2010; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NCT01235754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01235754.